A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

Nagoya Daini Red Cross Hospital, Nagoya

Nagoya City University Hospital, Nagoya

Kameda Medical Center, Kamogawa

Japanese Red Cross Narita Hospital, Narita

Ehime University Hospital, Touon

Nishigunma National Hospital, Shibukawa

Kobe City Medical Center General Hospital, Kobe

Hitachi General Hospital, Hitachi

Iwate Medical University, Morioka

Tokai University Hospital, Isehara

Tohoku University Hospital, Sendai

Kurashiki Central Hospital, Kurashiki

Kinki University Hospital, Faculty of Medicine, Sayama

Shizuoka Cancer Center, Sunto

National Disaster Medical Center, Tachikawa

Kagoshima Medical Center, Kagoshima

University Hospital, Kyoto Prefectural University of Medicine, Kyoto

Niigata Cancer Center Hospital, Niigata

Okayama Medical Center, Okayama

Osaka Red Cross Hospital, Osaka

National Cancer Center Hospital, Tokyo

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo

Japanese Red Cross Medical Center, Tokyo

Keio University Hospital, Tokyo